Adding Sickle Cell Disease To FDA ’s Priority Review Voucher List Of Neglected Tropical Diseases

Sickle cell disease lags behind other neglected diseases in terms of R&D. Adding sickle cell disease to the FDA ’s priority review voucher list of neglected tropical diseases may incentivize drug companies to increase their investment in R&D.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news